<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> 3-Mos <FISCAL-YEAR-END> Dec-31-1997<F1> <PERIOD-END> Mar-31-1997 <CASH> 1807 <SECURITIES> 495 <RECEIVABLES> 2715<F2> <ALLOWANCES> 0 <INVENTORY> 1738 <CURRENT-ASSETS> 7790 <PP&E> 6645 <DEPRECIATION> 2723 <TOTAL-ASSETS> 14860 <CURRENT-LIABILITIES> 5141 <BONDS> 961 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 108 <OTHER-SE> 6653 <TOTAL-LIABILITY-AND-EQUITY> 14860 <SALES> 4045 <TOTAL-REVENUES> 4045 <CGS> 1078 <TOTAL-COSTS> 1078 <OTHER-EXPENSES> 823 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 24 <INCOME-PRETAX> 1133 <INCOME-TAX> 323 <INCOME-CONTINUING> 810 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 810 <EPS-PRIMARY> .81 <EPS-DILUTED> 0 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.